Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
1.
Data Brief ; 50: 109607, 2023 Oct.
Article in English | MEDLINE | ID: mdl-37823067

ABSTRACT

The data presented in this article were collected in the field at an experimental station in southern France under a Mediterranean climate. Experiments were conducted under three plastic walk-in tunnels used as blocks with organic farming practices over two successive years in a completely randomized design. The aim was to compare the intercropping of sweet pepper with basil, onion, lettuce, parsley or French bean to a sole crop of sweet pepper used as a control. The dataset provides information on cultural practices with details on inputs and working times used to estimate economic costs. The data also describe the climatic conditions under tunnels as well as the dynamics of soil nitrate concentration and water tension over time through treatments. Yields, economic benefits and the rates of products with visual defects are presented. In addition, some variables applied exclusively to sweet pepper crops, namely nitrate concentration in petiole sap, growth parameters, abundance of aerial pests and beneficials, incidence of root necrosis, arbuscular mycorrhizal fungi colonization rates and diversity in roots. The field dataset is made publicly available to allow free and easy access for the scientific and professional community to enable analysis and reuse. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

2.
Rev Mal Respir ; 39(8): 708-718, 2022 Oct.
Article in French | MEDLINE | ID: mdl-36115751

ABSTRACT

Unlike the well-documented effects of tobacco smoke on the lung, the effects of cannabis smoke remain controversial, the main bias consisting in co-consumption of tobacco. That said, the composition of joint smoke is close to that of cigarettes, containing many compounds that are carcinogenic and/or alter the respiratory epithelium. Confirmed respiratory effects in chronic cannabis smokers include aggravated chronic bronchitis symptoms, a cumulative effect with tobacco on COPD and emphysema occurrence, an increased risk of bullous emphysema, and pneumothorax with heightened risk of recurrence after pleural symphysis. Recent prospective studies have shown a negative impact on lung function, with not only damage to the airways, but also DLCO alteration and an accelerated drop in FEV1. Finally, cannabis smoking is very common among young patients with lung cancer. Its consumption could lead to a different lung cancer profile, potentially more undifferentiated and less accessible to targeted therapy. Questioning about cannabis consumption must be systematic and targeted medical care should be offered.


Subject(s)
Cannabis , Emphysema , Lung Neoplasms , Marijuana Smoking , Pulmonary Emphysema , Tobacco Smoke Pollution , Cannabis/adverse effects , Emphysema/complications , Humans , Lung , Lung Neoplasms/complications , Lung Neoplasms/etiology , Marijuana Smoking/adverse effects , Marijuana Smoking/epidemiology , Pulmonary Emphysema/epidemiology , Pulmonary Emphysema/etiology
3.
Infect Dis Now ; 52(2): 68-74, 2022 Mar.
Article in English | MEDLINE | ID: mdl-35063702

ABSTRACT

OBJECTIVES: We aimed to understand the immune response among healthcare workers (HCWs) following SARS-CoV-2 infection, and to determine the infection prevalence during the first wave of the pandemic among workers in our hospital. METHODS: Determination of the serological status against SARS-CoV-2 (nucleocapsid) was offered to all HCWs. All HCWs with positive SARS-CoV-2 serology were proposed to be included in a longitudinal medical and serological follow-up (anti-spike) for 7months. RESULTS: We included 3062 HCWs; 256 (8.4%) were positive for anti-SARS-CoV-2 nucleocapsid IgG. Among them, early decrease in the anti-nucleocapsid antibody index was observed between the first (S1) and second (S2) serology samplings in 208 HCWs (84.2%). The initial anti-nucleocapsid IgG index seemed to be related to the HCWs' age. Seventy-four HCWs were included in the 7-month cohort study. Among them, 69 (90.5%) had detectable anti-spike IgG after 7months and 24 (32.4%) reported persistent symptoms consistent with post-acute COVID-19 syndrome diagnosis. CONCLUSION: The prevalence of serological positivity among HCWs was 6.7%. Infection should be followed by vaccination because of antibody decrease.


Subject(s)
Antibodies, Viral/blood , COVID-19 , Health Personnel , COVID-19/complications , COVID-19/immunology , Cohort Studies , France , Humans , Immunity , SARS-CoV-2 , Post-Acute COVID-19 Syndrome
4.
Diagn Interv Imaging ; 102(1): 19-26, 2021 Jan.
Article in English | MEDLINE | ID: mdl-33020025

ABSTRACT

PURPOSE: The purpose of this study was to compare efficacy and tolerance between radiofrequency ablation (RFA) and surgery for the treatment of oligometastatic lung disease. MATERIALS AND METHODS: This retrospective study reviewed patients treated in two institutions for up to 5 pulmonary metastases with a maximal diameter of 4cm and without associated pleural involvement or thoracic lymphadenopathy. Patient demographics, tumor characteristics, treatment outcome, and length of hospital stay were compared between the two groups. Efficacy endpoints were overall survival (OS), progression-free survival (PFS) and pulmonary or local tumor progression rates. RESULTS: Among 204 patients identified, 78 patients (42 men, 36 women; mean age, 53.3±14.9 [SD]; age range: 15-81 years) were treated surgically, while 126 patients (59 men, 67 women; mean age, 62.2±10.8 [SD]; age range: 33-80 years) were treated by RFA. In the RFA cohort, patients were significantly older (P<0.0001), with more extra-thoracic localisation (P=0.015) and bilateral tumour burden (P=0.0014). In comparison between surgery and RFA cohorts, respectively, the 1- and 3-year OS were 94.8 and 67.2% vs. 94 and 72.1% (P=0.46), the 1- and 3-year PFS were 49.4% and 26.1% vs. 38.9% and 14.8% (P=0.12), the pulmonary progression rates were 39.1% and 56% vs. 41.2% and 65.3% (P>0.99), and the local tumour progression rates were 5.4% and 10.6% vs. 4.8% and 18.6% (P=0.07). Tumour size>2cm was associated with a significantly higher local tumor progression in the RFA group (P=0.010). Hospitalisation stay was significantly shorter in the RFA group (median of 3 days; IQR=2 days; range: 2-12 days) than in the surgery group (median of 9 days; IQR=2 days; range: 6-21 days) (P<0.01). CONCLUSION: RFA should be considered a minimally-invasive alternative with similar OS and PFS to surgery in the treatment of solitary or multiple lung metastases measuring less than 4cm in diameter without associated pleural involvement or thoracic lymphadenopathy.


Subject(s)
Catheter Ablation , Liver Neoplasms , Lung Neoplasms , Radiofrequency Ablation , Adolescent , Adult , Aged , Aged, 80 and over , Female , Humans , Liver Neoplasms/surgery , Lung Neoplasms/surgery , Male , Middle Aged , Retrospective Studies , Survival Rate , Treatment Outcome , Young Adult
5.
Cancer Radiother ; 24(1): 67-72, 2020 Feb.
Article in French | MEDLINE | ID: mdl-32037126

ABSTRACT

Concomitant radiochemotherapy has been the standard of care for unresectable stage III non-small cell lung cancer (NSCLC), irrespective of histological sub-type or molecular characteristics. Currently, only 15-30 % of patients are alive five years after radiochemotherapy, and this figure remains largely unchanged despite multiple phase III randomised trials. In recent years, immune-checkpoint blockades with anti-PD-(L)1 have revolutionised the care of metastatic NSCLC, becoming the standard front- and second-line strategy. Several preclinical studies reported an increased tumour antigen release, improved antigen presentation, and T-cell infiltration in irradiated tumours. Immunotherapy has therefore recently been evaluated for patients with locally advanced stage III NSCLC. Following the PACIFIC trial, the anti-PD-L1 durvalumab antibody has emerged as a new standard consolidative treatment for patients with unresectable stage III NSCLC whose disease has not progressed following concomitant platinum-based chemoradiotherapy. Immunoradiotherapy therefore appears to be a promising association in patients with localised NSCLC. Many trials are currently evaluating the value of concomitant immunotherapy and chemoradiotherapy and/or consolidative chemotherapy with immunotherapy in patients with locally advanced unresectable NSCLC.


Subject(s)
Antineoplastic Agents, Immunological/therapeutic use , Carcinoma, Non-Small-Cell Lung/therapy , Lung Neoplasms/therapy , Antibodies, Monoclonal/therapeutic use , Carcinoma, Non-Small-Cell Lung/immunology , Chemotherapy, Adjuvant , Clinical Trials as Topic , Humans , Lung Neoplasms/immunology , Programmed Cell Death 1 Receptor/antagonists & inhibitors , Radiotherapy, Adjuvant
9.
Rev Mal Respir ; 33(2): 117-27, 2016 Feb.
Article in French | MEDLINE | ID: mdl-26346415

ABSTRACT

INTRODUCTION: Omalizumab, an anti-immunoglobulin E monoclonal antibody, has now been used for ten years as an add-on therapy for severe adult atopic asthma, poorly controlled by high-doses inhaled steroids and long-acting beta-agonists. BACKGROUND: This innovative therapy has been the first biotherapy used on a large scale in severe asthma. It has shown clinical benefits, especially in the prevention of severe exacerbation, with a satisfactory safety profile. Despite its cost, it is an interesting alternative to continuous oral steroids, which cause more long-term side effects. PERSPECTIVES: After ten-years of prescription of omalizumab, we review here the mechanism of action, the benefits, the main side effects, the cost-effectiveness and also the alternative indications of this interesting molecule. We also consider the practicalities of using omalizumab, particularly the importance a rigorous assessment of its efficacy after 16 weeks of treatment, and possible future therapeutic indications. CONCLUSION: Omalizumab has proven its efficacy in large randomized studies but also in real life practice in severe allergic asthma.


Subject(s)
Asthma/drug therapy , Drug Prescriptions , Omalizumab/therapeutic use , Anti-Asthmatic Agents/therapeutic use , Antibodies, Anti-Idiotypic/therapeutic use , Asthma/epidemiology , Drug Prescriptions/statistics & numerical data , Humans , Practice Patterns, Physicians'/statistics & numerical data , Practice Patterns, Physicians'/trends , Treatment Outcome
10.
Rev Mal Respir ; 32(6): 629-38, 2015 Jun.
Article in French | MEDLINE | ID: mdl-26163989

ABSTRACT

The management of asthma treatment is likely to change in coming years, with the development of a more personalized approach. Biological therapies targeting Th2 cytokines (IL-4, IL-5 and IL-13) offer new treatment pathways for patients with severe asthma and high Th2 activity. Bronchial thermoplasty is the only treatment for severe asthma that could provide a long standing effect, but many questions still remain and its use is restricted to clinical research. Weight loss should be a goal during long-term management of obese asthmatics. Involvement of a new inflammatory pathway including IL-1 and IL-17 in a murine model of obesity and asthma may lead to new therapies in this subgroup of asthmatics.


Subject(s)
Asthma/therapy , Therapies, Investigational , Abatacept/therapeutic use , Adult , Anti-Asthmatic Agents/therapeutic use , Antibodies, Monoclonal/therapeutic use , Antibodies, Monoclonal, Humanized , Asthma/complications , Asthma/immunology , Humans , Laser Coagulation/adverse effects , Laser Coagulation/methods , Lymphocytes/drug effects , Lymphocytes/immunology , Obesity/complications , Obesity/therapy , Therapies, Investigational/adverse effects , Therapies, Investigational/trends
11.
Rev Mal Respir ; 32(4): 413-34, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25596800

ABSTRACT

The occurrence of pulmonary fibrosis in numerous individuals from the same family suggests a genetic cause for the disease. During the last 10 years, mutations involving proteins from the telomerase complex and from the surfactant system have been identified in association with pulmonary fibrosis. Mutations of TERT, the coding gene for the telomerase reverse transcriptase, are the most frequently identified mutations and are present in 15% of cases of familial pulmonary fibrosis. Other mutations (TERC, surfactant proteins genes) are only rarely evidenced in adults. Patients with mutations involving the telomerase complex may present with pulmonary fibrosis, hematologic, cutaneous or liver diseases. Other genetic variations associated with pulmonary fibrosis such as a polymorphism in the promoter of MUC5B or a polymorphism in TERT have been recently described, and could be considered to be part of a polygenic transmission. Evidence for mutations associated with the development of pulmonary fibrosis raises numerous clinical questions from establishing a diagnosis, providing counselling to deciding on therapy, and requires specific studies. From a pathophysiological point of view, the function of the genes highlights the central role of alveolar epithelium and aging in fibrogenesis.


Subject(s)
Idiopathic Pulmonary Fibrosis/genetics , Telomerase/genetics , Humans , Idiopathic Pulmonary Fibrosis/diagnosis , Mutation
12.
Rev Pneumol Clin ; 70(1-2): 118-21, 2014.
Article in French | MEDLINE | ID: mdl-24566027

ABSTRACT

We report the case of a 57-year-old woman who presented with massive hemoptysis and thoracic pain 3 years after the endovascular treatment of a thoracic aortic aneurysm. Emergency work up revealed the presence of an endoleak, leading to the pressurization of the aneurysm sac and its subsequent rupture into the lung parenchyma. The discussion includes presentation, clinical course, diagnosis, complications and new therapeutic options in the management of a massive hemoptysis secondary to aortic rupture. All together, the case and discussion highlight the classical rules of critical care and the recent advances in endovascular treatment of thoracic aortic rupture.


Subject(s)
Aortic Aneurysm, Thoracic/surgery , Aortic Rupture/surgery , Endovascular Procedures/adverse effects , Hemoptysis/etiology , Female , Humans , Middle Aged
13.
Chemosphere ; 85(10): 1555-62, 2011 Nov.
Article in English | MEDLINE | ID: mdl-21868052

ABSTRACT

Ultrafine particulate matters enriched with metals are emitted into the atmosphere by industrial activities and can impact terrestrial and aquatic ecosystems. Thus, this study investigated the environmental effects of process particles from a lead-recycling facility after atmospheric deposition on soils and potential run-off to surface waters. The toxicity of lead-enriched PM for ecosystems was investigated on lettuce and bacteria by (i) germination tests, growth assays, lead transfer to plant tissues determination and (ii) Microtox analysis. The influence of ageing and soil properties on metal transfer and ecotoxicity was studied using three different soils and comparing various aged, spiked or historically long-term polluted soils. Finally, lead availability was assessed by 0.01 M CaCl(2) soil extraction. The results showed that process PM have a toxic effect on lettuce seedling growth and on Vibrio fischeri metabolism. Soil-PM interactions significantly influence PM ecotoxicity and bioavailability; the effect is complex and depends on the duration of ageing. Solubilisation or stabilisation processes with metal speciation changes could be involved. Finally, Microtox and phytotoxicity tests are sensitive and complementary tools for studying process PM ecotoxicity.


Subject(s)
Air Pollutants/toxicity , Industrial Waste , Lead/toxicity , Particulate Matter/toxicity , Soil Pollutants/toxicity , Soil , Air Pollutants/pharmacokinetics , Aliivibrio fischeri/drug effects , Biological Availability , Germination , Industrial Waste/analysis , Lead/pharmacokinetics , Lactuca/drug effects , Lactuca/growth & development , Soil Pollutants/pharmacokinetics , Time Factors , Toxicity Tests
14.
J Hazard Mater ; 186(2-3): 1018-27, 2011 Feb 28.
Article in English | MEDLINE | ID: mdl-21211904

ABSTRACT

Most available studies on lead smelter emissions deal with the environmental impact of outdoor particles, but only a few focus on air quality at workplaces. The objective of this study is to physically and chemically characterize the Pb-rich particles emitted at different workplaces in a lead recycling plant. A multi-scale characterization was conducted from bulk analysis to the level of individual particles, to assess the particles properties in relation with Pb speciation and availability. Process PM from various origins were sampled and then compared; namely Furnace and Refining PM respectively present in the smelter and at refinery workplaces, Emissions PM present in channeled emissions. These particles first differed by their morphology and size distribution, with finer particles found in emissions. Differences observed in chemical composition could be explained by the industrial processes. All PM contained the same major phases (Pb, PbS, PbO, PbSO(4) and PbO·PbSO(4)) but differed on the nature and amount of minor phases. Due to high content in PM, Pb concentrations in the CaCl(2) extractant reached relatively high values (40 mg L(-1)). However, the ratios (soluble/total) of CaCl(2) exchangeable Pb were relatively low (<0.02%) in comparison with Cd (up to 18%). These results highlight the interest to assess the soluble fractions of all metals (minor and major) and discuss both total metal concentrations and ratios for risk evaluations. In most cases metal extractability increased with decreasing size of particles, in particular, lead exchangeability was highest for channeled emissions. Such type of study could help in the choice of targeted sanitary protection procedures and for further toxicological investigations. In the present context, particular attention is given to Emissions and Furnace PM. Moreover, exposure to other metals than Pb should be considered.


Subject(s)
Environmental Monitoring/methods , Environmental Pollution/statistics & numerical data , Industrial Waste/analysis , Lead/chemistry , Recycling/methods , Aging/physiology , Crystallization , Epidemiological Monitoring , Humans , Lead Poisoning/epidemiology , Lung/metabolism , Metals/analysis , Microscopy, Electron, Scanning , Occupational Exposure , Particle Size , Risk Assessment , Spectrum Analysis, Raman , X-Ray Diffraction
15.
Environ Pollut ; 157(4): 1178-85, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19027209

ABSTRACT

Particles from channelled emissions of a battery recycling facility were size-segregated and investigated to correlate their speciation and morphology with their transfer towards lettuce. Microculture experiments carried out with various calcareous soils spiked with micronic and sub-micronic particles (1650+/-20mg Pb kg(-1)) highlighted a greater transfer in soils mixed with the finest particles. According to XRD and Raman spectroscopy results, the two fractions presented differences in the amount of minor lead compounds like carbonates, but their speciation was quite similar, in decreasing order of abundance: PbS, PbSO(4), PbSO(4) x PbO, alpha-PbO and Pb(0). Morphology investigations revealed that PM(2.5) (i.e. Particulate Matter 2.5 composed of particles suspended in air with aerodynamic diameters of 2.5 microm or less) contained many Pb nanoballs and nanocrystals which could influence lead availability. The soil-plant transfer of lead was mainly influenced by size and was very well estimated by 0.01M CaCl(2) extraction.


Subject(s)
Air Pollutants/toxicity , Industrial Waste , Lactuca/metabolism , Lead/toxicity , Soil Pollutants/toxicity , Air Pollutants/analysis , Air Pollutants/pharmacokinetics , Biological Availability , Biological Transport , Calcium Chloride/metabolism , Ecotoxicology/instrumentation , Ecotoxicology/methods , Industrial Waste/analysis , Lead/analysis , Lead/pharmacokinetics , Microscopy, Electron, Scanning , Particle Size , Soil Pollutants/analysis , Soil Pollutants/pharmacokinetics , Spectrum Analysis, Raman
16.
Chemosphere ; 71(11): 2187-92, 2008 May.
Article in English | MEDLINE | ID: mdl-18355894

ABSTRACT

Phytoremediation appears to be a promising technique for metal soil clean up, although its successful application on a large scale still remains a challenge. Field experiments for six scented Pelargonium cultivars, conducted on two Pb-contaminated calcareous and acidic soils, revealed vigorous plant growth, with no symptoms of morpho-phytotoxicity in spite of high Pb accumulation levels. Lead contents in the harvestable parts of all plants grown on the acidic and more contaminated soil were significantly higher than those grown on the calcareous soil. Three cultivars (Attar of Roses, Clorinda and Atomic Snowflake) are Pb-hyperaccumulator plants: they accumulated more than 1,000 mg Pb kg(-1)DW, with high biomass produced.


Subject(s)
Lead/metabolism , Pelargonium/metabolism , Biodegradation, Environmental , Biomass , France , Pelargonium/growth & development
SELECTION OF CITATIONS
SEARCH DETAIL
...